Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease: an expert opinion of the Italian diabetes society
Dosing typically ranges from 500-1000 mcg daily in oral form, or 1000 mcg monthly via intramuscular injection for those with absorption issues
The big question is: which of the two should you use
Fatigue or headaches Rare but can occur in individuals sensitive to peptides affecting metabolic pathways
The indications approved by the Central Drugs Standard Control Organization (CDSCO) in India are: 1) alcoholic fatty liver, 2) alcoholic liver fibrosis, 3) alcoholic liver cirrhosis, and 4) alcoholic hepatitis [4]
Regulatory standards also require precise control of formulation composition, packaging materials, storage conditions, and degradation products